ADH-1 is the most-studied N-cadherin inhibitor, and in vitro and clinical experiments have proven that apoptosis can be induced in many kinds of tumor cells to improve drug sensitivity [18,20,21]. This evidence concerns the gene ADH1A and neoplasm.